Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Autoimmune hepatitis characterized by the presence of antibodies to soluble liver or liver-pancreas antigens.
Biomarker and diagnostic research for autoimmune hepatitis type 3 has been reported in the published literature.
No clinical trials have been registered for autoimmune hepatitis type 3.
3 publications have been identified in PubMed for autoimmune hepatitis type 3. Research spans Other (33%), Diagnostic / Biomarker (33%), and Epidemiology / Natural History (33%).
Yoon D (2026). [PMID: 41495095](https://pubmed.ncbi.nlm.nih.gov/41495095/). *Scientific reports*. [Epidemiology / Natural History]
Shao YJ (2025). [PMID: 41316484](https://pubmed.ncbi.nlm.nih.gov/41316484/). *Arthritis research & therapy*. [Other]
Moral K (2024). [PMID: 39006139](https://pubmed.ncbi.nlm.nih.gov/39006139/). *Hepatology forum*. [Diagnostic / Biomarker]
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 1:11 PM UTC